Equities

One Glove Group Bhd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
ONEGLOVE:KLS

One Glove Group Bhd

Actions
Health CareMedical Equipment and Services
  • Price (MYR)0.135
  • Today's Change0.005 / 3.85%
  • Shares traded40.20k
  • 1 Year change-42.55%
  • Beta0.5138
Data delayed at least 15 minutes, as of Feb 16 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

One Glove Group Berhad is a Malaysia-based investment holding company. The Company is involved in the manufacturing, marketing and selling of examination gloves. The Company’s segments include Investment Holding, Glove Manufacturing, and Others. The Company’s products include Ultraviolet, Violet Blue, Cobalt Blue, Sky Blue and Black. Its gloves are non-sterile, powder-free, nitrile and ambidextrous. The Company’s subsidiary is Onetexx Sdn. Bhd.

  • Revenue in MYR (TTM)37.17m
  • Net income in MYR-30.30m
  • Incorporated2002
  • Employees286.00
  • Location
    One Glove Group BhdNo. 54-4-8Wisma Sri Mata, Jalan Van PraaghKAMUNTING 34600MalaysiaMYS
  • Phone+60 58913333
  • Fax+60 58919333
  • Websitehttps://www.oneglovegroup.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Adventa Bhd56.29m1.80m44.31m1.11k12.490.51214.790.78710.01160.01160.22090.3070.5086--2.65--1.610.47791.850.6046--17.953.170.72233.2811.790.0915--56.3114.04124.13--62.21--
Careplus Group Bhd100.44m-76.80m57.96m2.90k--0.2701--0.577-0.1045-0.10450.13620.27770.30923.585.29---23.93---28.16---14.99---77.40--1.14-13.430.1616--16.78---212.77------
One Glove Group Bhd37.17m-30.30m78.67m286.00--1.06--2.12-0.0548-0.05480.06720.18410.09393.975.27129,980.20-7.66---8.28---32.51---81.51--0.5535-4.230.5377--9.73--31.63------
Comfort Gloves Bhd360.55m-98.99m81.61m1.70k--0.1115--0.2264-0.1711-0.17110.62351.260.40615.535.67---11.15---12.51---17.9928.01-27.4615.673.95--0.0608--6.41-7.45-51.82---5.21--
Hextar Healthcare Bhd154.23m-21.56m95.47m646.00--0.182--0.619-0.0196-0.01960.13990.43950.27981.442.46238,750.50-3.916.51-4.127.2238.2655.60-13.9813.053.94-6.010.013---5.05-7.6478.38---30.25--
UMediC Group Bhd49.67m8.07m114.04m165.0014.131.399.942.300.02160.02160.13280.2190.55741.572.51--9.3011.7610.1313.6845.6540.7816.6916.904.66154.290.0143---11.0115.45-9.5327.4547.48--
Iconic Worldwide Bhd51.08m1.23m118.09m442.0094.590.648929.642.310.00070.00070.03030.10790.16970.83227.66--0.409--0.4637--24.27--2.41--0.66521.230.3455--------------
Crest Group Bhd175.23m10.71m194.76m154.0012.531.8114.031.110.0180.0180.23990.12571.399.473.43--9.17--13.46--24.82--6.62--3.16116.960.0176---2.47---41.04------
Sancy Bhd3.03m6.27m237.71m--38.637.7037.0378.530.00910.00910.00430.04540.1027--0.9748--21.29--22.51--62.95--207.26----693.850.0027---34.34--36.82------
LAC Med Bhd-100.00bn-100.00bn386.00m----6.93----------0.1392------------------------1.31--0.2927--21.86---1.66------
Data as of Feb 16 2026. Currency figures normalised to One Glove Group Bhd's reporting currency: Malaysian Ringgit MYR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.